@conference{8db4da88896741c199216d32a735b879,
title = "Phase 2 trial of durvalumab and radiation revaccination in patients with metastatic adenocarcinoma of the pancreas who have progressed through first-line chemotherapy.",
author = "Chuong, \{Michael David\} and Badiyan, \{Shahed Nicolas\} and Mehta, \{Minesh P.\}",
note = "TPS461 Background: Emerging data suggest that immunotherapy combined with radiation therapy (RT) can lead to robust anti-tumor immune responses within many tumor types. While not highly immunogenic, pancreatic cancer has been shown to respond to immunotherapy especially when combined with RT.; Journal of Clinical Oncology ; Conference date: 01-01-2020",
year = "2019",
month = feb,
day = "1",
doi = "10.1200/JCO.2019.37.4\_suppl.TPS461",
language = "American English",
}